Biotech startups in the Nordics
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| ADCendo | Copenhagen | Series C | $75.0M | 2026-04-14 |
| Mavatar | Stockholm | Seed | $3.9M | 2024-09-01 |
| Onego Bio | Helsinki | Series B | $28.0M | 2026-10-26 |
| Moleculent | Solna | Series A | $20.0M | 2026-04-30 |
| Asgard Therapeutics | Lund | Series A | $32.6M | 2024-03-14 |
| Again | Copenhagen | Series A | $43.1M | 2024-07-17 |
| Octarine Bio | Copenhagen | Series A | $5.9M | 2026-01-22 |
| Invert | Copenhagen | Seed | $20.1M | 2024-07-10 |
8 rows of the CSV in 5 of its 18 columns.
- The 198 biotech startups in the Nordics have raised $2.4B in total.
- 31 of them closed their most recent round in the last 12 months, $473.7M combined.
- The largest of those rounds is Sidera Bio's $109.0M Series A, dated December 2025.
- The most recent is Vitroscope's $5.0M seed round on 3 November 2026.
- Novo Holdings is an investor in 6 of them, more than any other fund.
- Health care is the most common other sector, with 139 companies (70%).
- 38% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (55% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 198| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Onego Bio | Onego Bio produces egg protein through fermentation as a food ingredient. | Biotech | Helsinki, Finland | Series B | $28.0M | 2026-10-26 | $100.6M | European Innovation Council, Business Finland, Tesi +2 | 11 to 50 | 2022 |
| Pixelgen Technologies | Pixelgen Technologies develops technologies for biomedical research and diagnostics. | Biotech | Stockholm, Sweden | Series B | $15.5M | 2026-08-20 | $43.5M | Industrifonden, Navigare Ventures, Colibri Ventures +1 | 11 to 50 | 2020 |
| Alcolase | Alcolase is a Danish life science start-up developing treatments for alcohol flushing. | Biotech | Copenhagen, Denmark | Seed | $1.7M | 2026-05-18 | $2.6M | Antler | 1 to 10 | 2021 |
| Moleculent | Moleculent is a biotechnology research company. | Biotech | Solna, Sweden | Series A | $20.0M | 2026-04-30 | $46.0M | ARCH Venture Partners, EIR Ventures | 11 to 50 | 2021 |
| ADCendo | ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. | Biotech | Copenhagen, Denmark | Series C | $75.0M | 2026-04-14 | $324.6M | RA Capital Management, Novo Holdings, Gilde Healthcare +2 | 51 to 100 | 2017 |
| Cellevate | Cellevate develops cell culture systems for biotech research and production. | Biotech | Lund, Sweden | Seed | $2.2M | 2026-03-30 | $12.1M | European Innovation Council, Industrifonden, Onsight Ventures +1 | 11 to 50 | 2014 |
| ENZIDIA | ENZIDIA develops enzyme acceleration technology for biomanufacturing. | Biotech | Kongens Lyngby, Denmark | Angel | $241K | 2026-03-16 | $865K | Innovation Fund Denmark | 1 to 10 | 2024 |
| Biomia | Biomia develops plant-derived natural products for unmet medical needs using synthetic biology. | Biotech | Lyngby, Denmark | Seed | $3.0M | 2026-02-09 | $3.0M | BlueYard Capital, Amino Collective, Nucleus Capital | 1 to 10 | 2022 |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. | Biotech | Copenhagen, Denmark | Series A | $5.9M | 2026-01-22 | $15.5M | MassChallenge, Vaekstfonden, Unconventional Ventures +2 | 11 to 50 | 2018 |
| Seaqure Labs AB | Seaqure Labs develops mycoprotein-based alternatives to current unsustainable methods used in aquaculture. | Biotech | Gothenburg, Sweden | Pre-seed | $546K | 2025-08-21 | $1.1M | Chalmers Ventures AB | 1 to 10 | 2024 |
| Trackpaw Scientific | TrackPaw Scientific develops and commercializes a technology platform for accelerating medication development. | Biotech | Lund, Sweden | Seed | $2.7M | 2025-08-18 | $3.1M | Almi Invest, I Love Lund, LU Holding | 1 to 10 | 2022 |
| SNIPR Biome | SNIPR Biome develops discovery-stage biotech treatments for microbial diseases. | Biotech | Copenhagen, Denmark | Series B | $40.9M | 2025-08-07 | $103.4M | Wellington Partners, Bill & Melinda Gates Foundation, EQT Life Sciences +1 | 11 to 50 | 2017 |
| Single Technologies | Single Technologies develops a 3-D DNA sequencing system. | Artificial intelligence | Stockholm, Sweden | Seed | $11.6M | 2025-06-24 | $28.6M | Almi Invest, Sting, KTH Holding +1 | 11 to 50 | 2014 |
| Droplet IV | Droplet IV develops automated technology for intravenous infusion therapy to reduce nursing workload. | Biotech | Kongens Lyngby, Denmark | Seed | $2.0M | 2025-06-17 | $4.0M | MedTech Innovator, BioInnovation Institute Venture Lab, BioInnovation Institute Venture House | 1 to 10 | 2022 |
| TILT Biotherapeutics | TILT Biotherapeutics develops therapies that enable the immune system to attack tumors. | Biotech | Helsinki, Finland | Series B | $25.3M | 2025-05-13 | $71.1M | European Innovation Council, Business Finland, Lifeline Ventures +1 | 11 to 50 | 2013 |
| MedTrace Pharma | MedTrace Pharma helps doctors diagnose critically ill patients faster and more accurately. | Biotech | Lyngby, Denmark | Series F | $11.1M | 2025-05-12 | $63.4M | European Innovation Council, Vaekstfonden, ATP +1 | 11 to 50 | 2015 |
| Commit Biologics | Commit Biologics develops a novel immunotherapy platform for treating cancer. | Biotech | Aarhus, Denmark | Seed | $5.7M | 2025-01-28 | $23.7M | Novo Holdings, Innovation Fund Denmark, Bioqube Ventures | 11 to 50 | 2021 |
| Mavatar | Mavatar develops AI and digital twin technology to reduce medication errors. | Artificial intelligence | Stockholm, Sweden | Seed | $3.9M | 2024-09-01 | Collinstar Capital | 11 to 50 | 2021 | |
| Nygen Analytics | Nygen Analytics provides cloud-based tools for cost-effective analysis of single-cell genomic data. | Biotech | Lund, Sweden | Seed | $734K | 2024-08-29 | $734K | Fåhraeus Startup and Growth, SmiLe Inject Capital | 1 to 10 | 2021 |
| Arcana Bio | Arcana Bio applies proteomics and AI to develop biotech diagnostics delivered as software. | Biotech | Reykjavík, Iceland | Seed | $554K | 2024-08-29 | $853K | New Business Venture Fund | 1 to 10 | 2018 |
| NADMED | NADMED brings a new NAD metabolite measurement technology to market. | Biotech | Helsinki, Finland | Series A | $3.9M | 2024-08-22 | Business Finland, Voima Ventures, Nordic Science Investments | 11 to 50 | 2022 | |
| Again | Again is a carbon utilization company that converts carbon emissions into valuable chemicals. | Biotech | Copenhagen, Denmark | Series A | $43.1M | 2024-07-17 | Google Ventures, HV Capital, ACME Capital +1 | 11 to 50 | 2020 | |
| Invert | Invert provides AI-driven software that supports real-time decisions in bioprocessing. | Artificial intelligence | Copenhagen, Denmark | Seed | $20.1M | 2024-07-10 | $20.6M | Y Combinator, Giant Ventures | 11 to 50 | 2021 |
| BrainZell | BrainZell uses stem cell-based models that more closely match the human brain than animal models. | Biotech | Stockholm, Sweden | Seed | $1.5M | 2024-06-03 | Sting, Norrsken Evolve | 1 to 10 | 2020 | |
| Enifer | Enifer produces mycoprotein by fungal fermentation, upcycling agrifood industry byproducts. | Biotech | Espoo, Finland | Series B | $16.2M | 2024-05-23 | Tesi, Finnvera Venture Capital, Voima Ventures +1 | 11 to 50 | 2020 | |
| Reshape Biotech | Reshape Biotech builds lab robots that automate routine microbiology tasks like plate filling and image analysis. | Artificial intelligence | Kongens Lyngby, Denmark | Series A | $20.0M | 2024-04-09 | Y Combinator, FundersClub, Astanor Ventures | 11 to 50 | 2018 | |
| Asgard Therapeutics | Asgard Therapeutics is a biotechnology company developing new therapies. | Biotech | Lund, Sweden | Series A | $32.6M | 2024-03-14 | $39.6M | Novo Holdings, Industrifonden, Boehringer Ingelheim Venture Fund +2 | 11 to 50 | 2018 |
| Infinited Fiber Company | Infinited Fiber Company works to make circular fashion and textiles an everyday reality. | Biotech | Espoo, Finland | Series B | $29.5M | 2024-03-08 | Business Finland, European Commission | 51 to 100 | 2016 | |
| Calluna Pharma | Calluna Pharma develops first-in-class therapies that target chronic inflammation and fibrosis at their source. | Biotech | Oslo, Norway | Series A | $81.4M | 2024-01-23 | Forbion Capital Partners, Investinor, Sarsia +1 | 11 to 50 | 2024 | |
| Hoba Therapeutics | Hoba Therapeutics develops a new therapeutic protein for treating neuropathic pain. | Biotech | Copenhagen, Denmark | Series A | $24.8M | 2023-12-11 | European Innovation Council, EIC Accelerator, Novo Holdings +2 | 1 to 10 | 2016 |
Table 1. Biotech startups in the Nordics: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 198.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ADCendo | ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. | Biotech | Copenhagen, Denmark | Series C | $75.0M | 2026-04-14 | $324.6M | RA Capital Management, Novo Holdings, Gilde Healthcare +2 | 51 to 100 | 2017 |
| 2 | Onego Bio | Onego Bio produces egg protein through fermentation as a food ingredient. | Biotech | Helsinki, Finland | Series B | $28.0M | 2026-10-26 | $100.6M | European Innovation Council, Business Finland, Tesi +2 | 11 to 50 | 2022 |
| 3 | Moleculent | Moleculent is a biotechnology research company. | Biotech | Solna, Sweden | Series A | $20.0M | 2026-04-30 | $46.0M | ARCH Venture Partners, EIR Ventures | 11 to 50 | 2021 |
| 4 | Pixelgen Technologies | Pixelgen Technologies develops technologies for biomedical research and diagnostics. | Biotech | Stockholm, Sweden | Series B | $15.5M | 2026-08-20 | $43.5M | Industrifonden, Navigare Ventures, Colibri Ventures +1 | 11 to 50 | 2020 |
| 5 | Octarine Bio | Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. | Biotech | Copenhagen, Denmark | Series A | $5.9M | 2026-01-22 | $15.5M | MassChallenge, Vaekstfonden, Unconventional Ventures +2 | 11 to 50 | 2018 |
| 6 | Biomia | Biomia develops plant-derived natural products for unmet medical needs using synthetic biology. | Biotech | Lyngby, Denmark | Seed | $3.0M | 2026-02-09 | $3.0M | BlueYard Capital, Amino Collective, Nucleus Capital | 1 to 10 | 2022 |
| 7 | Cellevate | Cellevate develops cell culture systems for biotech research and production. | Biotech | Lund, Sweden | Seed | $2.2M | 2026-03-30 | $12.1M | European Innovation Council, Industrifonden, Onsight Ventures +1 | 11 to 50 | 2014 |
| 8 | Alcolase | Alcolase is a Danish life science start-up developing treatments for alcohol flushing. | Biotech | Copenhagen, Denmark | Seed | $1.7M | 2026-05-18 | $2.6M | Antler | 1 to 10 | 2021 |
| 9 | ENZIDIA | ENZIDIA develops enzyme acceleration technology for biomanufacturing. | Biotech | Kongens Lyngby, Denmark | Angel | $241K | 2026-03-16 | $865K | Innovation Fund Denmark | 1 to 10 | 2024 |
Table 2. Biotech startups in the Nordics: the 9 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Novo Holdings | Corporate venture arm | Hellerup, Denmark | 6 | 3% | 1 | ADCendo |
| 2 | Business Finland | Government investment office | Helsinki, Finland | 5 | 3% | 1 | Onego Bio |
| 3 | European Innovation Council | Startup accelerator | Brussels, Belgium | 5 | 3% | 2 | Onego Bio, Cellevate |
| 4 | Tesi | Government investment office | Helsinki, Finland | 4 | 2% | 1 | Onego Bio |
| 5 | Export and Investment Fund | Government investment office | Hellerup, Denmark | 4 | 2% | ||
| 6 | Vaekstfonden | Venture capital firm | Hellerup, Denmark | 4 | 2% | 1 | Octarine Bio |
| 7 | Industrifonden | Venture capital firm | Stockholm, Sweden | 3 | 2% | 2 | Pixelgen Technologies, Cellevate |
| 8 | Voima Ventures | Venture capital firm | Helsinki, Finland | 3 | 2% | ||
| 9 | BioInnovation Institute Venture Lab | Startup accelerator | Copenhagen, Denmark | 3 | 2% | ||
| 10 | Chalmers Ventures AB | Venture capital firm | Gothenburg, Sweden | 3 | 2% | ||
| 11 | Y Combinator | Startup accelerator | Mountain View, United States | 2 | 1% | ||
| 12 | SmiLe Incubator | Startup accelerator | Lund, Sweden | 2 | 1% | 1 | Cellevate |
| 13 | Lifeline Ventures | Venture capital firm | Helsinki, Finland | 2 | 1% | ||
| 14 | Innovation Fund Denmark | Government investment office | Copenhagen, Denmark | 2 | 1% | 1 | ENZIDIA |
| 15 | BioInnovation Institute Venture House | Startup accelerator | Copenhagen, Denmark | 2 | 1% |
Table 3. Biotech startups in the Nordics: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 139 | 70% | $2.1B |
| Software | 26 | 13% | $152.3M |
| Artificial intelligence | 17 | 9% | $81.1M |
| Hardware | 8 | 4% | $2.2M |
| Fintech | 2 | 1% | $1.4M |
| Commerce | 1 | 1% | |
| Education | 1 | 1% | |
| Energy | 1 | 1% |
Table 4. Biotech startups in the Nordics by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in the Nordics by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
Table 6. Biotech startups in the Nordics by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Copenhagen | 41 | 21% |
| Stockholm | 18 | 9% |
| Helsinki | 14 | 7% |
| Gothenburg | 11 | 6% |
| Aarhus | 10 | 5% |
| Oslo | 9 | 5% |
| Solna | 8 | 4% |
| Lund | 8 | 4% |
| Lyngby | 6 | 3% |
| Kongens Lyngby | 5 | 3% |
| Uppsala | 5 | 3% |
| Trondheim | 4 | 2% |
Table 7. Biotech startups in the Nordics by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 6% | $5.8M |
| October 2026 | 2 | 6% | $28.4M |
| September 2026 | 8 | 26% | $153.6M |
| August 2026 | 1 | 3% | $15.5M |
| July 2026 | 1 | 3% | $515K |
| June 2026 | 2 | 6% | $1.2M |
| May 2026 | 1 | 3% | $1.7M |
| April 2026 | 2 | 6% | $95.0M |
| March 2026 | 5 | 16% | $8.3M |
| February 2026 | 2 | 6% | $7.7M |
| January 2026 | 2 | 6% | $41.0M |
| December 2025 | 3 | 10% | $114.9M |
Table 8. Biotech startups in the Nordics: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 28 | 14% | $358.8M |
| 2025 | 28 | 14% | $464.1M |
| 2024 | 28 | 14% | $404.7M |
| 2023 | 19 | 10% | $131.5M |
| 2022 | 17 | 9% | $119.5M |
| 2021 | 14 | 7% | $99.4M |
Table 9. Biotech startups in the Nordics by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 27 | 14% |
| 2020 to 2022 | 48 | 24% |
| 2015 to 2019 | 64 | 32% |
| 2010 to 2014 | 32 | 16% |
| Before 2010 | 26 | 13% |
Table 10. Biotech startups in the Nordics by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 105 | 55% |
| 11 to 50 | 77 | 40% |
| 51 to 100 | 5 | 3% |
| 101 to 250 | 2 | 1% |
| 251 to 500 | 2 | 1% |
Table 11. Biotech startups in the Nordics by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in the Nordics. On 16 November 2026 that is 198 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 198 rows: 43 have no round amount, 0 no city and 66 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in the Nordics are on the list?
- 198, in the file dated 16 November 2026. 31 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 198 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.